The PCRT mission is to organize and accelerate the clinical development of new agents for the treatment of patients with pancreatic cancer. PCRT is an international collaborative organization formed by several world renowned institutions and researchers. PCRT conducts clinical trials in patients with pancreatic cancer, translating genomics research into prevention, diagnosis and treatment.
PCRT members include laboratory and clinical researchers in the U.S. and Europe, who share the passion to rapidly bring new advances to pancreatic cancer patients; PCRT provides the only coordinated effort in the world dedicated to swiftly translating research discoveries into new treatments and supportive care for patients with pancreatic cancer. All phases of clinical research are supported through PCRT.
To date, the PCRT consortium includes approximately 75 Oncology Clinicians, Surgeons and Researchers who are member-investigators of PCRT representing 45 research sites.
The Pancreatic Cancer Research Team's ( PCRT's) ultimate goal is to eradicate and cure pancreatic cancer. On the way to this goal, the team wants to improve the prognosis and quality of life for patients with pancreatic cancer. The PCRT is an international collaborative organization formed by several world renowned institutions and researchers. READ MORE/LESS:
PCRT conducts clinical trials through a network of pancreatic cancer physicians who are translating genomics research into prevention, diagnosis and treatment of this disease.
For information on the clinical trials open in the PCRT Network or to find the nearest PCRT physician near you, please click here.
The PCRT network provides the drug and diagnostics industries with access to an unrivaled worldwide network of clinical experts in pancreatic cancer, led by key thought-leaders in this field. The PCRT provides a central resource to biotech and pharma companies seeking strategies and clinical resources. For more information on how PCRT can add value to your next pancreatic cancer clinical trial, please click here.